1 / 6

COLISTINA POLVERE INALATORIA

TIP has a safety and efficacy profile comparable with TIS, and offers a far more convenient treatment option for pseudomonas lung infection in CF . Konstan M et al. J Cyst Fibros Volume 10, Issue 1 , January 2011, Pages 54–61. COLISTINA POLVERE INALATORIA.

moana
Download Presentation

COLISTINA POLVERE INALATORIA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TIP has a safety and efficacy profile comparable with TIS, and offers a far more convenient treatment option for pseudomonas lung infection in CF. Konstan M et al. J Cyst FibrosVolume 10, Issue 1, January 2011, Pages 54–61

  2. COLISTINA POLVERE INALATORIA Colistin Dry Powder for Inhalation demonstrated efficacy by virtue of non-inferiority to TIS in lung function after 24 weeks of treatment. There was no emergence of resistance of P aeruginosa to colistin. Overall, CDPI was well tolerated

  3. The international community is making a huge investment in future research: National CF registries Recent estimates of CF patients in registries world wide (2009-2012 data) UK >9,500 Norway >250 Europe* >19,000 Canada >3,800 Australia >3,100 USA >27,000 New Zealand >400 *- 20 countries, 10 of which have country registries

More Related